Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence — Revenue, Volume, Production, Trade Analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034 |
|---|---|
| Product Type Segment | Accessories, Reagents and Kits, Software, Instruments |
| Component Segment | Plasma, Whole Blood |
| End-User Segment | Hospitals, Pathology Labs, Diagnostic Clinics, Blood Banks |
|---|---|
| Regions & Countries |
|
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
The contract is made with Medical Technology Enterprise Consortium (METEC) sponsored by the Defense Health Agency (DHA) and managed by the Naval Medical Research Center (NMRC) to drive healthcare advances for the battlefield.
A long-time agreement has been signed between the Canadian blood service and Grifols, a major market player in plasma medicines which will lead to a significant increase in immunoglobulin medicines and vital plasma protein this will ensure domestic plasma self-sufficiency.
| Company | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| SpecialityCare | ••• | ••• | ••• | ••• |
| Haemonetics Corporation | ••• | ••• | ••• | ••• |
| Baden Wuerttemberg Hessen | ••• | ••• | ••• | ••• |
| UPMC | ••• | ••• | ••• | ••• |
| B BRAUN | ••• | ••• | ••• | ••• |
| Instrumentation Laboratory | ••• | ••• | ••• | ••• |
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
Request company profile for validation →The patient blood management market was valued at USD 12.93 billion in 2022 and will reach USD 20.60 billion by 2030, registering a CAGR of 6% for the forecast period 2023-2030.
Patient blood management (PBM) is a procedure in which maximum use of a patient's own blood is obtained to avoid unnecessary blood transfusions during surgery. Patient blood management helps to reduce healthcare costs and ensures the availability of blood components to the patient. The rising recognition of the importance of donated blood from the many sectors of the healthcare system, placenta research, and life sciences for the development of the medical industry is a significant factor in boosting the growth of the Patient blood management Market.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Patient Blood Management Market Analysis is witnessing significant growth in the near future. In 2023, the Accessories segment accounted for a notable share of the Global Patient Blood Management Market Analysis.Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Patient Blood Management Market Analysis is witnessing significant growth in the near future.
In 2023, the Accessories segment accounted for a notable share of the Global Patient Blood Management Market Analysis.
★ Reviews
Rate this report
| Product Type | Accessories, Reagents and Kits, Software, Instruments |
| Component | Plasma, Whole Blood |
| End-User | Hospitals, Pathology Labs, Diagnostic Clinics, Blood Banks |
| List of Competitors | SpecialityCare, Haemonetics Corporation, Baden Wuerttemberg Hessen, UPMC, B BRAUN, Instrumentation Laboratory |
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Global Patient Blood Management Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Global Patient Blood Management Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the global patient blood management market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.